Study to Assess GW642444 in Asthma Patients

NCT00381667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GW642444M
DRUG: GW642444H
OTHER: placebo

Sponsor

GlaxoSmithKline